These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7986181)

  • 1. A brief history of the use of interferons as treatment of multiple sclerosis.
    Jacobs L; Johnson KP
    Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
    Sim IS; Cerruti RL
    Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons and multiple sclerosis.
    Clanet M; Blancher A; Calvas P; Rascol O
    Biomed Pharmacother; 1989; 43(5):355-60. PubMed ID: 2477075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.
    van der Meide PH; Harteveld N; Stebbing N; Schellekens H
    Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferons in dermatology.
    Stadler R; Mayer-da-Silva A; Bratzke B; Garbe C; Orfanos C
    J Am Acad Dermatol; 1989 Apr; 20(4):650-6. PubMed ID: 2497154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications for clinical application of new developments in interferon research.
    Taylor-Papadimitriou J; Balkwill FR
    Biochim Biophys Acta; 1982 Sep; 695(1):49-67. PubMed ID: 6182911
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
    Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N
    Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferons--biologic principles and clinical uses].
    Jacobsen H; Kirchner H
    Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interferon system as a basis for antiviral therapy or prophylaxis.
    Billiau A
    Antiviral Res; 1985; Suppl 1():131-40. PubMed ID: 3936410
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of clonogenic assays in assessing the response of human lung cancer cell lines to alpha and gamma interferons alone or in combination with adriamycin.
    Jabbar SA; Twentyman PR
    Int J Cancer; 1990 Sep; 46(3):546-51. PubMed ID: 2118486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.
    Bartsch HH; Pfizenmaier K; Hanusch A; Scheurich P; Ucer U; Nagel GA
    Int J Cancer; 1989 Feb; 43(2):235-40. PubMed ID: 2521842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of human breast cancer xenografts using natural interferons-alpha and -gamma injected singly or in combination.
    Ozzello L; Habif DV; De Rosa CM; Cantell K
    J Interferon Res; 1988 Oct; 8(5):679-90. PubMed ID: 3148672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1984; 13():176-84. PubMed ID: 6085167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical uses of interferons.
    Friedman RM
    Br J Clin Pharmacol; 2008 Feb; 65(2):158-62. PubMed ID: 18070219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.